AI assistant
GlaxoSmithKline PLC — Share Issue/Capital Change 2018
May 10, 2018
5262_rns_2018-05-10_f94fdb9e-e111-4848-a5bb-67dcec702f2a.html
Share Issue/Capital Change
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 7281N
GlaxoSmithKline PLC
10 May 2018
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 10 May 2018
| Name of applicant: | GlaxoSmithKline plc | |||
| Name of scheme: | GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan | |||
| Period of return: | From: | 1 November 2017 | To: | 30 April 2018 |
| Balance of unallotted securities under scheme(s) from previous return: | 199,082 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 165,219 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 33,863 | |||
| Name of contact: | Victoria Whyte |
| Telephone number of contact: | 020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 10 May 2018
| Name of applicant: | GlaxoSmithKline plc | |||
| Name of scheme: | GlaxoSmithKline Share Option Plan - Ordinary Shares | |||
| Period of return: | From: | 1 November 2017 | To: | 30 April 2018 |
| Balance of unallotted securities under scheme(s) from previous return: | 3,559,772 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 865,821 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 2,693,951 | |||
| Name of contact: | Victoria Whyte |
| Telephone number of contact: | 020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 10 May 2018
| Name of applicant: | GlaxoSmithKline plc | |||
| Name of scheme: | GlaxoSmithKline Share Option Plan - ADS | |||
| Period of return: | From: | 1 November 2017 | To: | 30 April 2018 |
| Balance of unallotted securities under scheme(s) from previous return: | 8,185,120 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 275,126 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 7,909,994 | |||
| Name of contact: | Victoria Whyte |
| Telephone number of contact: | 020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 10 May 2018
| Name of applicant: | GlaxoSmithKline plc | |||
| Name of scheme: | GlaxoSmithKline plc Share Save Plan 2012 | |||
| Period of return: | From: | 1 November 2017 | To: | 30 April 2018 |
| Balance of unallotted securities under scheme(s) from previous return: | 1,542,070 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 714,764 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 827,306 | |||
| Name of contact: | Victoria Whyte |
| Telephone number of contact: | 020 8047 5000 |
The following GlaxoSmithKline plc Employee Share Schemes have expired and therefore will no longer be included in Block Listing Six Monthly Returns:
1. Glaxo Wellcome UK Share Option Scheme
2. Glaxo Wellcome International Share Option Scheme
3. Glaxo Wellcome 1999 Share Option Plan
4. SmithKline Beecham 1989 Executive Share Option Plan - Approved - Ordinary Shares
5. SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - ADS
6. SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - Ordinary
This information is provided by RNS
The company news service from the London Stock Exchange
END
BLRMMGMKVGVGRZM